These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39034308)

  • 1. Baseline hepatobiliary MRI for predicting chemotherapeutic response and prognosis in initially unresectable colorectal cancer liver metastases.
    Chen Y; Lu T; Zhang Y; Li H; Xu J; Li M
    Abdom Radiol (NY); 2024 Aug; 49(8):2585-2594. PubMed ID: 39034308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine.
    Brismar TB; Kartalis N; Kylander C; Albiin N
    Eur Radiol; 2012 Mar; 22(3):633-41. PubMed ID: 21953376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative and quantitative parameters on hepatobiliary phase of gadoxetic acid-enhanced MR imaging for predicting pathological response to preoperative systemic therapy in colorectal liver metastases.
    Gu XL; Cui Y; Wang K; Xing Q; Li XT; Zhu HT; Li ZW; Sun YS
    Eur J Radiol; 2022 Dec; 157():110572. PubMed ID: 36327859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing predictions: improved performance of preoperative gadobenate-enhanced MRI hepatobiliary phase features in predicting vessels encapsulating tumor clusters in hepatocellular carcinoma-a multicenter study.
    Chen H; Dong H; He R; Gu M; Zhao X; Song K; Zou W; Jia N; Liu W
    Abdom Radiol (NY); 2024 Oct; 49(10):3412-3426. PubMed ID: 38713432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting chemotherapeutic response for colorectal liver metastases using relative tumor enhancement of gadoxetic acid disodium-enhanced magnetic resonance imaging.
    Murata S; Matsushima S; Sato Y; Yamaura H; Kato M; Hasegawa T; Muro K; Inaba Y
    Abdom Radiol (NY); 2018 Dec; 43(12):3301-3306. PubMed ID: 29666951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
    Khouri Chalouhi C; Vernuccio F; Rini F; Duca P; Tuscano B; Brancatelli G; Vanzulli A
    Eur Radiol; 2019 Jun; 29(6):3090-3099. PubMed ID: 30547205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascites relative enhancement during hepatobiliary phase after Gd-BOPTA administration: a new promising tool for characterising abdominal free fluid of unknown origin.
    Bonatti M; Valletta R; Zamboni GA; Lombardo F; Senoner M; Simioni M; Schifferle G; Bonatti G
    Eur Radiol; 2019 Jun; 29(6):2830-2836. PubMed ID: 30643946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
    Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
    Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the performance of hepatobiliary agents in depicting MRI features of microvascular infiltration in hepatocellular carcinoma.
    Yao WW; Zhang HW; Ma YP; Lee JM; Lee RT; Wang YL; Liu XL; Shen XP; Huang B; Lin F
    Abdom Radiol (NY); 2024 Jul; 49(7):2242-2249. PubMed ID: 38824474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
    Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
    Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases.
    Wei J; Cheng J; Gu D; Chai F; Hong N; Wang Y; Tian J
    Med Phys; 2021 Jan; 48(1):513-522. PubMed ID: 33119899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A
    J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX.
    Wang X; Wang Y; Zhang Z; Zhou M; Zhou X; Zhao H; Xing J; Zhou Y
    Eur J Radiol; 2021 Oct; 143():109887. PubMed ID: 34454297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
    Torkzad MR; Riddell AM; Chau I; Cunningham D; Koh DM
    AJR Am J Roentgenol; 2021 Mar; 216(3):669-676. PubMed ID: 33502225
    [No Abstract]   [Full Text] [Related]  

  • 15. Whole tumor based texture analysis of magnetic resonance diffusion imaging for colorectal liver metastases: A prospective study for diffusion model comparison and early response biomarker.
    Li Y; Zhang H; Yue L; Fu C; Grimm R; Li W; Guo W; Tong T
    Eur J Radiol; 2024 Jan; 170():111203. PubMed ID: 38007855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation.
    Della Corte A; Mori M; Calabrese F; Palumbo D; Ratti F; Palazzo G; Pellegrini A; Santangelo D; Ronzoni M; Spezi E; Del Vecchio A; Fiorino C; Aldrighetti L; De Cobelli F
    Int J Hyperthermia; 2024; 41(1):2349059. PubMed ID: 38754994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis versus focal eosinophilic infiltration of the liver in patients with extrahepatic abdominal cancer: an evaluation with gadobenate dimeglumine-enhanced magnetic resonance imaging.
    Park MS; Kim MJ; Lim JS; Kim SH; Kim HS; Chung YE; Kim KW
    J Comput Assist Tomogr; 2009; 33(1):119-24. PubMed ID: 19188798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Ability of Gadobenate Dimeglumine and Gadolinium Ethoxybenzyl Dimeglumine to Display the major Features for Noninvasively Diagnosing Hepatocellular Carcinoma According to the LI-RADS 2018v.
    Yao WW; Zhang HW; M YP; Lee JM; Lee RT; Wang YL; Liu XL; Shen XP; Huang B; Lin F
    Technol Cancer Res Treat; 2024; 23():15330338241260331. PubMed ID: 38860337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
    Dioguardi Burgio M; Picone D; Cabibbo G; Midiri M; Lagalla R; Brancatelli G
    Abdom Radiol (NY); 2016 Aug; 41(8):1546-54. PubMed ID: 27052455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Local Tumor Progression After Microwave Ablation in Colorectal Carcinoma Liver Metastases Patients by MRI Radiomics and Clinical Characteristics-Based Combined Model: Preliminary Results.
    Shahveranova A; Balli HT; Aikimbaev K; Piskin FC; Sozutok S; Yucel SP
    Cardiovasc Intervent Radiol; 2023 Jun; 46(6):713-725. PubMed ID: 37156944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.